Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 May 2025 for Rigel Pharmaceuticals INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Anthony Gregg Lapointe: trading record in brief
Anthony Gregg Lapointe appears in our data through filings on Rigel Pharmaceuticals Inc shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 19 May 2021 and the latest from 23 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 28 May 2025, the filings show a share grant in Rigel Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anthony Gregg Lapointe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,500 shares0Common StockSEC:0000905148-25-001933:0
25,000 shares0Common StockSEC:0000905148-24-001654:0
25,000 shares0Common StockSEC:0001140361-23-034286:0
25,000 shares0Common StockSEC:0001140361-22-020306:0
25,000 shares0Common StockSEC:0001179110-21-005766:0
5 of 5 declarations
